SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-053506
Filing Date
2024-04-29
Accepted
2024-04-29 08:05:30
Documents
13
Period of Report
2024-04-26
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2412857d1_8k.htm   iXBRL 8-K 23889
  Complete submission text file 0001104659-24-053506.txt   197738

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA coll-20240426.xsd EX-101.SCH 3036
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE coll-20240426_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE coll-20240426_pre.xml EX-101.PRE 22373
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2412857d1_8k_htm.xml XML 3700
Mailing Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072
Business Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072 781-713-3699
COLLEGIUM PHARMACEUTICAL, INC (Filer) CIK: 0001267565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37372 | Film No.: 24886679
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)